Key Quantitative Figures (Q1 FY27)

Consolidated Performance:

  • Revenue from Operations: ₹2,592 crore (35% YoY growth; 22% QoQ growth)
  • EBITDA: ₹554 crore (159% YoY growth; 45% QoQ growth)
  • EBITDA Margin: 21% (vs. 11% in Q1 FY26 and 18% in Q4 FY26)
  • Profit Before Tax (PBT): ₹468 crore (202% YoY growth; 55% QoQ growth)
  • Profit After Tax (PAT): ₹345 crore (207% YoY growth; 57% QoQ growth)
  • Domestic to Export Revenue Mix: 85:15
  • Consolidated Net Worth: ₹6,214 crore
  • Debt-to-Equity Ratio: 0.27x

Segment Performance:

Phenolics Business:

  • Revenue: ₹1,775 crore (36% YoY growth; 24% QoQ growth)
  • EBIT: ₹418 crore (254% YoY growth; 46% QoQ growth)
  • EBIT Margin: 24%

Advanced Intermediates (AI) Business:

  • Revenue: ₹804 crore (33% YoY growth; 14% QoQ growth)
  • EBIT: ₹67 crore (89% YoY growth; 100% QoQ growth)
  • EBIT Margin: 8%

Strategic Updates & Project Commissioning

Recently Commissioned/Stabilized Assets:

  • Ammonia-to-amines integration chain is completed and stabilized.
  • Nitration and reduction facilities commissioned in Q3 of the previous year are operating with high utilization.

Imminent Commissioning (Q2 FY27):

  • MIBK, MIBC, and acetophenone projects are confirmed for commissioning in August 2026.
  • A multipurpose agrochemical intermediates facility is on track for commissioning within Q2 FY27.

Major Capex Project (Deepak Chemtech):

  • The integrated propylene-to-polycarbonate project has a total outlay of ₹11,500 crore, with a debt-to-equity funding ratio of 60:40.
  • The entire debt has been tied up at competitive rates.
  • Capex spent to date: Approximately ₹1,200 crore.
  • Planned capex for FY27: An additional ₹1,000-1,500 crore (Total FY27 spend: ~₹2,200-2,700 crore).
  • Projected peak debt: ₹8,000-8,500 crore (including working capital), with a debt-to-equity not exceeding 1x.
  • Execution Timeline: Polycarbonate commissioning targeted for H2 FY28-29; Bisphenol A (BPA) commissioning targeted a couple of months after polycarbonate.

Capacity & Debottlenecking:

  • The existing phenol plant is undergoing debottlenecking with an investment of ~₹70-80 crore to increase capacity towards 400,000 tonnes per annum (from the current run-rate of nearly 100,000 tonnes per quarter).
  • The company has invested in advanced process controls to achieve higher capacity and maintain best-in-class product quality.

Management Commentary & Rationale

Performance Drivers: The record performance was attributed to improved market conditions, stronger manufacturing efficiencies, integrated benefits from recently commissioned assets, innovative procurement, cost optimization, and healthy volume growth across businesses.

R&D and Future Pipeline: The R&D platform has a robust pipeline across fluorination, amination, nitration, and specialty chemistries. Products are progressing through customer qualifications. The company is also investing in flow chemistry and digitization to improve efficiency and introduce new products with better margin profiles.

Market Outlook: Management expressed optimism about the medium-to-long-term outlook, citing improving demand visibility, recently commissioned capacities, and expanding downstream offerings. The company believes it is well-positioned to navigate geopolitical and pricing volatility due to its integrated and diversified platform.

Q&A Session Highlights

Phenol Capacity: Management confirmed the plant achieved a run-rate close to 100,000 tonnes in parts of the quarter and is targeting an annualized capacity of 400,000 tonnes after further debottlenecking.

Raw Material Sourcing (Propylene): The team secured propylene competitively despite volatility in Q1. The situation has improved in the current quarter, and future competitiveness will be enhanced once propylene supply begins from the Propane Dehydrogenation (PDH) plant.

Product Approvals: Product quality for MIBK and MIBC has been approved by customers and is considered best-in-class. Pre-commissioning runs have already achieved target raw material and utility norms.

Margin Sustainability: Management refrained from commenting on specific spreads but emphasized the company's operational excellence and competitive procurement capabilities provide a structural advantage.

Exports & Logistics: The company is addressing global supply chain disruptions and rising freight costs through customer engagement, changing product compositions (e.g., for hazardous cargo), and exploring larger parcel shipments to consolidate costs.

#Tags: #DeepakNitrite #Q1Earnings #SEBIDisclosure #RegulatoryCompliance #FinancialUpdate #Positive